Drug Information

Drug General Information
Drug ID
D0IA5O
Former ID
DIB011261
Drug Name
GSK-2241658A
Synonyms
NY-ESO-1 ASCI (melanoma), GSK; Recombinant NY-ESO-1 antigen immunotherapeutic vaccine (melanoma), GlaxoSmithKline; 2241658A
Drug Type
Vaccine
Indication Melanoma [ICD9: 172; ICD10:C43] Phase 1 [523193]
Company
GlaxoSmithKline plc
Target and Pathway
Target(s) NY-ESO-1 Target Info [523193]
References
Ref 523193ClinicalTrials.gov (NCT01213472) Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma. U.S. National Institutes of Health.
Ref 523193ClinicalTrials.gov (NCT01213472) Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma. U.S. National Institutes of Health.